Ameriprise
PRME icon

Ameriprise’s Prime Medicine PRME Stock Holding History

Ameriprise’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
49,941
+357
+0.7% +$1.19K ﹤0.01% 3973
2026
Q1 		$173K Sell
49,584
-4,498
-8% -$17.1K ﹤0.01% 3907
2025
Q4 		$188K Sell
54,082
-7,490
-12% -$33.3K ﹤0.01% 3938
2025
Q3 		$341K Buy
+61,572
New +$250K ﹤0.01% 3754
2024
Q4 		– Sell
-28,801
Closed -$111K – 4143
2024
Q3 		$111K Sell
28,801
-1,095
-4% -$5.07K ﹤0.01% 3827
2024
Q2 		$154K Buy
+29,896
New +$181K ﹤0.01% 3724

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ameriprise's PRME Position: Q2 2026 in Review

Ameriprise increased its Prime Medicine (PRME) stake by 0.72% in Q2 2026, buying an estimated $1.19K and bringing the position to 49,941 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Ameriprise first reported a position in PRME in Q2 2024 and has held it in 6 quarters since. The position peaked at $341K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Ameriprise held 49,941 shares of Prime Medicine worth $184K as of Q2 2026.
  • Ameriprise bought 357 Prime Medicine shares in Q2 2026, an estimated $1.19K.
  • Prime Medicine made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3973 holding.
  • Ameriprise first reported a position in Prime Medicine in Q2 2024 and has held it in 6 quarters since.
  • Ameriprise's Prime Medicine position peaked at $341K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.